Gene · 197259
Papers4,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Single-Cell and Transcriptome Analysis with Experimental Validation Reveals PANoptosis-Related Gene Signatures in the Immune Microenvironment of Autoimmune Thyroiditis. | J Inflamm Res | 2025 | 40927355 | PubTator, text mining | PubMed |
| MLKL PARylation in the endothelial niche triggers angiocrine necroptosis to evade cancer immunosurveillance and chemotherapy. | Nat Cell Biol | 2025 | 40913147 | Swiss-Prot, curated | PubMed |
| STING and Nonnecroptotic MLKL-Mediated Mechanisms Improve Dendritic Cell Maturation and Killing of Cancer Cells. | Eur J Immunol | 2025 | 40899086 | PubTator, text mining | PubMed |
| Syncytial death mediated by oncolytic rVSV-NDV dynamically activates immunogenic apoptosis and necroptosis in human lung cancer cells. | Mol Ther Oncol | 2025 | 40896365 | PubTator, text mining | PubMed |
| PANoptosis-mediated mechanisms underlying AST elevation in Talaromyces marneffei infection. | PLoS Negl Trop Dis | 2025 | 40892762 | PubTator, text mining | PubMed |
| Diagnostic PANoptosis-related genes in acute kidney injury: bioinformatics, machine learning, and validation. | Ann Med | 2025 | 40891136 | PubTator, text mining | PubMed |
| Trimethylamine N-oxide Induced Chronic Kidney Injury by Triggering PANoptosis. | Physiol Res | 2025 | 40886370 | PubTator, text mining | PubMed |
| Unravelling neuronal death mechanisms: The role of cytokines and chemokines in immune imbalance in Alzheimer's disease progression. | Ageing Res Rev | 2025 | 40885312 | PubTator, text mining | PubMed |
| DJ-1 counteracts Caveolin-1-mediated necroptosis to inhibit epithelial barrier dysfunction in colitis. | Cell Death Dis | 2025 | 40877233 | PubTator, text mining | PubMed |
| Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury. | Cell Death Discov | 2025 | 40877228 | PubTator, text mining | PubMed |
| Spautin-1 inhibits the growth of diffuse large B-cell lymphoma by inducing mitochondrial damage-mediated PANoptosis and anti-tumor immunity. | Cancer Immunol Immunother | 2025 | 40853486 | PubTator, text mining | PubMed |
| Resistance to oncolytic virotherapy: Multidimensional mechanisms and therapeutic breakthroughs (Review). | Int J Mol Med | 2025 | 40849827 | PubTator, text mining | PubMed |
| Emerging dual role of ferroptosis in lung cancer (Review). | Oncol Rep | 2025 | 40849820 | PubTator, text mining | PubMed |
| Artemisinin toxicity in HepG2 liver carcinoma cells is linked to protein network in host and molecular interactions with cellular drug targets. | Chem Biol Interact | 2025 | 40846229 | PubTator, text mining | PubMed |
| Eryptosis in Liver Diseases: Contribution to Anemia and Hypercoagulation. | Med Sci (Basel) | 2025 | 40843747 | PubTator, text mining | PubMed |
| RPA1 protects DNA damage-induced PANoptosis in limb development. | Sci Adv | 2025 | 40834068 | PubTator, text mining | PubMed |
| Diverse functions of NLRP3 inflammasome in PANoptosis and diseases. | Cell Death Discov | 2025 | 40830103 | PubTator, text mining | PubMed |
| Cytotoxic granules and effector molecules from immune cells in tuberculosis: Mechanisms of host defense and therapeutic potential. | Virulence | 2025 | 40825006 | PubTator, text mining | PubMed |
| Dual role mechanisms of regulated cell death in apical periodontitis: from pathogenic destruction to therapeutic potential. | Cell Death Discov | 2025 | 40817074 | PubTator, text mining | PubMed |
| Cell death signaling and immune regulation: new perspectives on targeted therapy for sepsis. | Cell Mol Biol Lett | 2025 | 40817040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/197259/papers?page=17